Should babies get 13-valent pneumococcal vaccine? What effect does 13-valent pneumococcal vaccine have?

Vaccines are invented to improve children's resistance to certain diseases. From this perspective, all vaccines should be given. The price of the 13-valent pneumococcal vaccine is relatively expensive. If you don't consider your financial conditions, it is best to vaccinate your children. Let's take a closer look!

Should babies get 13-valent pneumonia vaccine?

The 13-valent pneumococcal vaccine currently used in China is an imported product of Pfizer: Prevnar 13. Pneumonia vaccine is still very necessary to be vaccinated. Pneumonia ranks second among the causes of death of children under five in my country. Every year, about 1.74 million children under five suffer from pneumonia, of which about 30,000 die from it.

Currently, only babies aged 6 weeks to 15 months can be vaccinated in China.

What is the role of 13-valent pneumonia vaccine?

Pneumococcal vaccine is an effective active immunization method to protect children from pneumococcal infection, but this vaccine does not mean that pneumonia will not occur. Nor does the 13-valent pneumococcal vaccine provide 100% protection against invasive pneumococcal diseases caused by the 13 serotypes contained in the vaccine. It can only provide about 80% protection.

Because the pneumococcal vaccine cannot completely protect children from pneumonia, nor can it 100% protect against infection by the vaccinated serotype of pneumococcus, the decision to vaccinate should be made based on the economic situation, the child's health, feeding methods, and possible adverse reactions.

13-valent pneumococcal vaccine process

1. For infants and young children aged 6 weeks to 15 months.

2. 0.5 mL per dose, 4 doses in total, intramuscular injection.

3. The first injection is usually given in 2 months; the next two injections are usually in April and June.

4. The last injection is between 1 year and 15 months.

5. The recommended dosing interval is 4 to 8 weeks; depending on the patient's age; the minimum dose interval for infants <1 year old is 4 weeks, and the minimum interval between the third and fourth doses is 8 weeks.